These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 18384626)

  • 1. The relationship between the local and systemic inflammatory responses and survival in patients undergoing resection for localized renal cancer.
    Lamb GW; McArdle PA; Ramsey S; McNichol AM; Edwards J; Aitchison M; McMillan DC
    BJU Int; 2008 Sep; 102(6):756-61. PubMed ID: 18384626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study of the relationship between the systemic inflammatory response, prognostic scoring systems and relapse-free and cancer-specific survival in patients undergoing potentially curative resection for renal cancer.
    Ramsey S; Lamb GW; Aitchison M; McMillan DC
    BJU Int; 2008 Apr; 101(8):959-63. PubMed ID: 18190639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased preoperative serum C-reactive protein level predicts a poor prognosis in patients with localized renal cell carcinoma.
    Komai Y; Saito K; Sakai K; Morimoto S
    BJU Int; 2007 Jan; 99(1):77-80. PubMed ID: 16956357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of peritumoral regulatory T cells and its correlation with intratumoral cyclooxygenase-2 expression in clear cell renal cell carcinoma.
    Li JF; Chu YW; Wang GM; Zhu TY; Rong RM; Hou J; Xu M
    BJU Int; 2009 Feb; 103(3):399-405. PubMed ID: 19021626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The longitudinal relationship between circulating concentrations of C-reactive protein, interleukin-6 and interleukin-10 in patients undergoing resection for renal cancer.
    Ramsey S; Lamb GW; Aitchison M; McMillan DC
    Br J Cancer; 2006 Oct; 95(8):1076-80. PubMed ID: 17003778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
    Yoo C; Song C; Hong JH; Kim CS; Ahn H
    J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The longitudinal relationship between the systemic inflammatory response, circulating T-lymphocytes, interleukin-6 and -10 in patients undergoing immunotherapy for metastatic renal cancer.
    Ramsey S; Aitchison M; Graham J; McMillan DC
    BJU Int; 2008 Jul; 102(1):125-9. PubMed ID: 18336617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-infiltrating Foxp3-CD4+CD25+ T cells predict poor survival in renal cell carcinoma.
    Siddiqui SA; Frigola X; Bonne-Annee S; Mercader M; Kuntz SM; Krambeck AE; Sengupta S; Dong H; Cheville JC; Lohse CM; Krco CJ; Webster WS; Leibovich BC; Blute ML; Knutson KL; Kwon ED
    Clin Cancer Res; 2007 Apr; 13(7):2075-81. PubMed ID: 17404089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer.
    Canna K; McArdle PA; McMillan DC; McNicol AM; Smith GW; McKee RF; McArdle CS
    Br J Cancer; 2005 Feb; 92(4):651-4. PubMed ID: 15700032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma.
    Yildiz E; Ayan S; Goze F; Gokce G; Gultekin EY
    BJU Int; 2008 Mar; 101(6):758-64. PubMed ID: 18070177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capsular involvement in patients undergoing partial nephrectomy for localized renal cell carcinoma: an adverse pathological finding?
    Rouach Y; Delongchamps N; Timsit MO; Verkarre V; Fontaine E; Peyromaure M; Mejean A
    BJU Int; 2010 Mar; 105(5):616-9. PubMed ID: 19681891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
    Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H
    Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of thrombocytosis and C-reactive protein elevation on the prognosis for patients with renal cell carcinoma.
    Ito K; Asano T; Yoshii H; Satoh A; Sumitomo M; Hayakawa M
    Int J Urol; 2006 Nov; 13(11):1365-70. PubMed ID: 17083384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of body mass index on the long-term survival of patients with renal cell carcinoma after tumour nephrectomy.
    Haferkamp A; Pritsch M; Bedke J; Wagener N; Pfitzenmaier J; Buse S; Hohenfellner M
    BJU Int; 2008 May; 101(10):1243-6. PubMed ID: 18261150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PD-1 is expressed by tumor-infiltrating immune cells and is associated with poor outcome for patients with renal cell carcinoma.
    Thompson RH; Dong H; Lohse CM; Leibovich BC; Blute ML; Cheville JC; Kwon ED
    Clin Cancer Res; 2007 Mar; 13(6):1757-61. PubMed ID: 17363529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-reactive protein is an informative predictor of renal cell carcinoma-specific mortality: a European study of 313 patients.
    Karakiewicz PI; Hutterer GC; Trinh QD; Jeldres C; Perrotte P; Gallina A; Tostain J; Patard JJ
    Cancer; 2007 Sep; 110(6):1241-7. PubMed ID: 17639589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of tumour-associated symptoms on the prognosis of patients with renal cell carcinoma.
    Kawaciuk I; Hyrsl L; Dusek P; Jarolim L; Schmidt M; Kaliska V; Chocholaty M; Vesely S
    Scand J Urol Nephrol; 2008; 42(5):406-11. PubMed ID: 18932106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perinephric and renal sinus fat infiltration in pT3a renal cell carcinoma: possible prognostic differences.
    Bedke J; Buse S; Pritsch M; Macher-Goeppinger S; Schirmacher P; Haferkamp A; Hohenfellner M
    BJU Int; 2009 May; 103(10):1349-54. PubMed ID: 19076147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of C-reactive protein kinetics on survival of patients with metastatic renal cell carcinoma.
    Saito K; Tatokoro M; Fujii Y; Iimura Y; Koga F; Kawakami S; Kihara K
    Eur Urol; 2009 May; 55(5):1145-53. PubMed ID: 18930583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of epithelial-mesenchymal transition markers in renal cell carcinoma: impact on prognostic outcomes in patients undergoing radical nephrectomy.
    Harada K; Miyake H; Kusuda Y; Fujisawa M
    BJU Int; 2012 Dec; 110(11 Pt C):E1131-7. PubMed ID: 22712620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.